CHMP var betænkelig ved, at undersøgelserne ikke havde vist nogen betydelige fordele ved Lacosamid Pain UCB Pharma.
The CHMP was concerned that the studies had not shown a meaningful benefit of Lacosamide Pain UCB Pharma.